U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...

As the FTSE 100's pharmaceutical giants nervously await possible US tariffs, could trade levies end up impacting NHS users?

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainant ... was taken verbatim from part of the summary of product characteristics, which had been approved ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

China announced on Friday that it would raise its levies on imports of U.S. goods to 125%, hitting back at U.S. President ...